PONTE VERDE, Fla., Sept. 10, 2025 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace” or the “Company”) (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the surgical treatment of bunions and related midfoot deformities, today announced it will highlight new product innovations and present new interim data for the ALIGN3D™ and MTA3D™ clinical studies at the American Orthopaedic Foot & Ankle Society (AOFAS) Annual Meeting 2025 in Savannah, Georgia from September 10-13, 202 ...

Korrektion til meddelelse af 01.09.2025, hvor datoen for, hvornår udbytte fragår kursen, var fejlagtigt angivet. Oplysningerne er korrigeret i nedenstående. Investeringsforeningen Nordea Invest udbetaler acontoudlodning for nedenstående afdelinger for perioden 1. januar 2025 til 30. juni 2025. Udlodningerne vil blive udbetalt til investorernes konti den 15. september 2025 og vil fragå kursen den 11. september 2025. Dato for sidste handelsdag, hvor udbyttet er inkluderet, er den 10. september 2025. Nordea In ...

IRVINE, Calif., Sept. 10, 2025 (GLOBE NEWSWIRE) -- Lantronix Inc. (NASDAQ: LTRX), a global leader in compute and connectivity IoT solutions powering Edge AI applications, today announced that its TAA/NDAA-compliant Open-Q™ System-on-Module (SOM) that is used in drone development for key manufacturers of defense unmanned aerial vehicles has won a 2025 IoT Evolution Product of the Year Award from IoT Evolution World, the leading Web site covering IoT technologies. “By strategically focusing on the drone marke ...

Oversubscribed Financing led by Coastlands Capital with participation from new and existing investors Financing to provide $50 million in upfront proceeds with the potential for up to an additional $50 million of proceeds to fund the Phase 1/2 clinical trial in patients with SYNGAP1-related disorders, expected to initiate as early as 2H 2026 Doug Williams, Ph.D., to become Board Chair, and Dan Tardiff, Ph.D., elevated to Chief Scientific Officer CAMBRIDGE, Mass., Sept. 10, 2025 (GLOBE NEWSWIRE) -- CAMP4 The ...

Planned flagship facility, expected to serve as foundation for a scalable clean fuels model, progressing toward pre-FEED stage at Northern BC site; to be supported by grant applications, including the federal Clean Fuels FundCALGARY, Alberta, Sept. 10, 2025 (GLOBE NEWSWIRE) -- Cielo Waste Solutions Corp. (TSXV: CMC; OTCQB: CWSFF) (“Cielo” or the “Company”) is proud to announce the launch of its first commercial project and flagship clean fuels initiative, Project Nexus (“Project Nexus”). The building of thi ...

SAN MATEO, Calif., Sept. 10, 2025 (GLOBE NEWSWIRE) -- Sagimet Biosciences Inc. (Sagimet, Nasdaq: SGMT), a clinical-stage biopharmaceutical company developing novel therapeutics targeting dysfunctional metabolic and fibrotic pathways, today announced that the Company will give two oral presentations and participate in a drug development panel at the 9th Annual MASH Drug Development Summit taking place September 29-October 1, 2025 in Boston, MA. The two presentations will cover combination treatment with a FA ...

This was unpaid research with no consideration givenTORONTO, Sept. 10, 2025 (GLOBE NEWSWIRE) -- Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) (FRA: 0K91) (Upstream: QNTM) (“Quantum BioPharma” or the “Company”), a biopharmaceutical company dedicated to building a portfolio of innovative assets and biotech solutions for the treatment of challenging neurodegenerative and metabolic disorders and alcohol misuse disorders with drug candidates in different stages of development, today announces Kingswood Capit ...

10 SEPTEMBER 2025DECISIONS OF THE RICHEMONT 2025 ANNUAL GENERAL MEETING Compagnie Financière Richemont SA (the "Company") held its 2025 Annual General Meeting ("AGM") in Geneva today. All agenda items were approved by the shareholders. The results for the year, including the proposals of the Board of Directors for the appropriation of retained earnings at 31 March 2025 were approved. An ordinary dividend of CHF 3.00 per 'A' share was approved and will be paid on the listed 'A' registered shares while a divi ...

SHANGHAI, Sept. 10, 2025 (GLOBE NEWSWIRE) -- ECARX Holdings Inc. (Nasdaq: ECX) (“ECARX” or the “Company”), a global mobility technology provider, recently unveiled a next-generation in-vehicle navigation system alongside the latest iteration of its Skyland® New intelligent driving solution through its collaboration with ecosystem partners at IAA Mobility 2025 in Munich, underscoring the ongoing execution of its innovative, scalable and internationally compliant technology roadmap. ECARX’s new global navigat ...

- Company plans to host an investor call at 8 a.m. ET on September 25 - - Immuneering plans to then share the updated data at the PanCAN Scientific Summit on September 28 - - Additionally, the Company will present a review of preclinical data on Deep Cyclic Inhibitors at the 7th RAS-Targeted Drug Development Summit - CAMBRIDGE, Mass., Sept. 10, 2025 (GLOBE NEWSWIRE) -- Immuneering Corporation (Nasdaq: IMRX), a clinical-stage oncology company focused on keeping cancer patients alive, today shared plans to an ...